• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核 miR-122 直接在转录后水平调控细胞存活致癌 miRNA miR-21 的生成。

Nuclear miR-122 directly regulates the biogenesis of cell survival oncomiR miR-21 at the posttranscriptional level.

机构信息

State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, Nanjing Advanced Institute for Life Sciences, School of Life Sciences, Nanjing University, Nanjing, Jiangsu 210093, China.

State Key Laboratory of Natural Medicines, Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing, Jiangsu 210009, China.

出版信息

Nucleic Acids Res. 2018 Feb 28;46(4):2012-2029. doi: 10.1093/nar/gkx1254.

DOI:10.1093/nar/gkx1254
PMID:29253196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5829740/
Abstract

Hepatic miR-122 can serve as a pro-apoptotic factor to suppress tumorigenesis. The underlying mechanism, however, remains incompletely understood. Here we present the first evidence that miR-122 promotes hepatocellular carcinoma cell apoptosis through directly silencing the biogenesis of cell survival oncomiR miR-21 at posttranscriptional level. We find that miR-122 is strongly expressed in primary liver cell nucleus but its nuclear localization is markedly decreased in transformed cells particularly in chemoresistant tumor cells. MiRNA profiling and RT-qPCR confirm an inverse correlation between miR-122 and miR-21 in hepatocellular carcinoma tissues/cells, and increasing or decreasing nuclear level of miR-122 respectively reduces or increases miR-21 expression. Mechanistically, nuclear miR-122 suppresses miR-21 maturation via binding to a 19-nt UG-containing recognition element in the basal region of pri-miR-21 and preventing the Drosha-DGCR8 microprocessor's conversion of pri-miR-21 into pre-miR-21. Furthermore, both in vitro and in vivo studies demonstrate that nuclear miR-122 participates in the regulation of HCC cell apoptosis through modulating the miR-21-targeted programmed cell death 4 (PDCD4) signal pathway.

摘要

肝 miR-122 可作为促凋亡因子抑制肿瘤发生。然而,其潜在机制尚不完全清楚。本文首次证明,miR-122 通过直接抑制细胞存活致癌 miRNA miR-21 的生物发生,在转录后水平促进肝细胞癌细胞凋亡。我们发现 miR-122 在原代肝细胞核中强烈表达,但在转化细胞,特别是在耐药肿瘤细胞中,其核定位明显减少。miRNA 谱分析和 RT-qPCR 证实了肝癌组织/细胞中 miR-122 和 miR-21 之间的负相关,并且分别增加或减少核 miR-122 的水平会降低或增加 miR-21 的表达。从机制上讲,核 miR-122 通过与 pri-miR-21 基本区域的 19nt UG 富含识别元件结合,阻止 Drosha-DGCR8 微处理器将 pri-miR-21 转化为 pre-miR-21,从而抑制 miR-21 的成熟。此外,体内外研究均表明,核 miR-122 通过调节 miR-21 靶向的程序性细胞死亡 4(PDCD4)信号通路参与 HCC 细胞凋亡的调节。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d07/5829740/d4219ce0698e/gkx1254fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d07/5829740/a57bc40225ee/gkx1254fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d07/5829740/c59c82760721/gkx1254fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d07/5829740/4d4ccb18318d/gkx1254fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d07/5829740/f9ff0f29f396/gkx1254fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d07/5829740/20e9dd8f5120/gkx1254fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d07/5829740/b46f0fe9d710/gkx1254fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d07/5829740/0d3252cc9d3f/gkx1254fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d07/5829740/d4219ce0698e/gkx1254fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d07/5829740/a57bc40225ee/gkx1254fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d07/5829740/c59c82760721/gkx1254fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d07/5829740/4d4ccb18318d/gkx1254fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d07/5829740/f9ff0f29f396/gkx1254fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d07/5829740/20e9dd8f5120/gkx1254fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d07/5829740/b46f0fe9d710/gkx1254fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d07/5829740/0d3252cc9d3f/gkx1254fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d07/5829740/d4219ce0698e/gkx1254fig8.jpg

相似文献

1
Nuclear miR-122 directly regulates the biogenesis of cell survival oncomiR miR-21 at the posttranscriptional level.核 miR-122 直接在转录后水平调控细胞存活致癌 miRNA miR-21 的生成。
Nucleic Acids Res. 2018 Feb 28;46(4):2012-2029. doi: 10.1093/nar/gkx1254.
2
miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma.miR-21 通过 miR-21-PDCD4-AP-1 反馈环促进人肝癌细胞的迁移和侵袭。
Oncol Rep. 2012 May;27(5):1660-8. doi: 10.3892/or.2012.1682. Epub 2012 Feb 9.
3
MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma.微小 RNA-21 通过多种靶点在人肝细胞癌中发挥致癌作用。
J Hepatol. 2010 Jul;53(1):98-107. doi: 10.1016/j.jhep.2010.02.021. Epub 2010 Apr 4.
4
MicroRNA-21 regulates the migration and invasion of a stem-like population in hepatocellular carcinoma.微小 RNA-21 调控肝癌干细胞样细胞的迁移和侵袭。
Int J Oncol. 2013 Aug;43(2):661-9. doi: 10.3892/ijo.2013.1965. Epub 2013 May 27.
5
The miR-93 promotes proliferation by directly targeting PDCD4 in hepatocellular carcinoma.miR-93 通过直接靶向 PDCD4 促进肝癌细胞增殖。
Neoplasma. 2017;64(5):770-777. doi: 10.4149/neo_2017_516.
6
microRNA-141 inhibits cell proliferation and invasion and promotes apoptosis by targeting hepatocyte nuclear factor-3β in hepatocellular carcinoma cells.微小RNA-141通过靶向肝癌细胞中的肝细胞核因子-3β抑制细胞增殖和侵袭并促进细胞凋亡。
BMC Cancer. 2014 Nov 25;14:879. doi: 10.1186/1471-2407-14-879.
7
Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.长链非编码RNA NEAT1通过调控miR-129-5p-VCP-IκB促进肝癌细胞增殖。
Am J Physiol Gastrointest Liver Physiol. 2017 Aug 1;313(2):G150-G156. doi: 10.1152/ajpgi.00426.2016. Epub 2017 May 19.
8
MicroRNA-31-5p regulates chemosensitivity by preventing the nuclear location of PARP1 in hepatocellular carcinoma.microRNA-31-5p 通过防止 PARP1 的核定位来调节肝癌的化疗敏感性。
J Exp Clin Cancer Res. 2018 Nov 6;37(1):268. doi: 10.1186/s13046-018-0930-0.
9
[Roles of miR-590-5p and miR-590-3p in the development of hepatocellular carcinoma].[miR-590-5p和miR-590-3p在肝细胞癌发生发展中的作用]
Nan Fang Yi Ke Da Xue Xue Bao. 2013 Jun;33(6):804-11.
10
MicroRNA-500a Promotes the Progression of Hepatocellular Carcinoma by Post-Transcriptionally Targeting BID.微小RNA-500a通过转录后靶向BID促进肝细胞癌进展。
Cell Physiol Biochem. 2018;47(5):2046-2055. doi: 10.1159/000491472. Epub 2018 Jul 3.

引用本文的文献

1
RNA Through Time: From the Origin of Life to Therapeutic Frontiers in Transcriptomics and Epitranscriptional Medicine.穿越时间的RNA:从生命起源到转录组学和表观转录组医学的治疗前沿
Int J Mol Sci. 2025 May 22;26(11):4964. doi: 10.3390/ijms26114964.
2
Targeting Regulatory Noncoding RNAs in Human Cancer: The State of the Art in Clinical Trials.靶向人类癌症中的调控性非编码RNA:临床试验的现状
Pharmaceutics. 2025 Apr 4;17(4):471. doi: 10.3390/pharmaceutics17040471.
3
MicroRNA-122 overexpression suppresses the colon cancer cell proliferation by downregulating the astrocyte elevated gene-1/metadherin oncoprotein.

本文引用的文献

1
Resolving Subcellular miRNA Trafficking and Turnover at Single-Molecule Resolution.以单分子分辨率解析亚细胞miRNA的运输与周转
Cell Rep. 2017 Apr 18;19(3):630-642. doi: 10.1016/j.celrep.2017.03.075.
2
MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways.微小RNA-122通过靶向胰岛素样生长因子1受体(IGF-1R)来调节RAS/RAF/ERK信号通路,从而赋予肝癌细胞对索拉非尼的抗性。
Cancer Lett. 2016 Feb 28;371(2):171-81. doi: 10.1016/j.canlet.2015.11.034. Epub 2015 Dec 3.
3
Hepatitis B virus-human chimeric transcript HBx-LINE1 promotes hepatic injury via sequestering cellular microRNA-122.
微小RNA-122的过表达通过下调星形胶质细胞升高基因-1/黏附素原癌蛋白来抑制结肠癌细胞增殖。
Ann Med. 2025 Dec;57(1):2478311. doi: 10.1080/07853890.2025.2478311. Epub 2025 Apr 10.
4
Comparison of Anticancer Effects between Platinum Levetiracetam and Platinum Azidothymidine through the Expression of Biomarker Genes on Cancer Cell Lines.通过癌细胞系中生物标志物基因的表达比较左乙拉西坦铂和齐多夫定铂的抗癌效果。
Avicenna J Med Biotechnol. 2025 Jan-Mar;17(1):24-30. doi: 10.18502/ajmb.v17i1.17674.
5
Therapeutic Potential of STE20-Type Kinase STK25 Inhibition for the Prevention and Treatment of Metabolically Induced Hepatocellular Carcinoma.STE20型激酶STK25抑制在预防和治疗代谢性诱导肝细胞癌中的治疗潜力
Cell Mol Gastroenterol Hepatol. 2025 Feb 28;19(7):101485. doi: 10.1016/j.jcmgh.2025.101485.
6
The Role of MicroRNAs in Liver Functioning: from Biogenesis to Therapeutic Approaches (Review).微小RNA在肝功能中的作用:从生物发生到治疗方法(综述)
Sovrem Tekhnologii Med. 2023;15(5):54-79. doi: 10.17691/stm2023.15.5.06. Epub 2023 Oct 30.
7
Circulating plasma derived exosomes from systemic lupus erythematosus aggravate lupus nephritis through miR-122-5p/FOXO3-mediated macrophage activation.系统性红斑狼疮患者循环血浆来源的外泌体通过miR-122-5p/FOXO3介导的巨噬细胞活化加重狼疮性肾炎。
J Nanobiotechnology. 2024 Dec 19;22(1):779. doi: 10.1186/s12951-024-03063-6.
8
Compartment-specific small non-coding RNA changes and nucleolar defects in human mesial temporal lobe epilepsy.人类内侧颞叶癫痫中的特定隔室小分子非编码 RNA 变化和核仁缺陷。
Acta Neuropathol. 2024 Nov 7;148(1):61. doi: 10.1007/s00401-024-02817-8.
9
miRNA biomarkers to predict risk of primary non-function of fatty allografts and drug induced acute liver failures.用于预测脂肪移植物原发性无功能和药物性急性肝衰竭风险的微小RNA生物标志物。
Mol Cell Biochem. 2025 Apr;480(4):2573-2593. doi: 10.1007/s11010-024-05129-3. Epub 2024 Oct 18.
10
MicroRNAs in Hepatocellular Carcinoma Pathogenesis: Insights into Mechanisms and Therapeutic Opportunities.微小 RNA 与肝细胞癌发病机制:对机制和治疗机会的深入了解。
Int J Mol Sci. 2024 Aug 29;25(17):9393. doi: 10.3390/ijms25179393.
乙肝病毒-人嵌合转录本HBx-LINE1通过隔离细胞微小RNA-122促进肝损伤。
J Hepatol. 2016 Feb;64(2):278-291. doi: 10.1016/j.jhep.2015.09.013. Epub 2015 Sep 25.
4
Importin 8 regulates the transport of mature microRNAs into the cell nucleus.Importin 8 调控成熟 microRNAs 向细胞核内的转运。
J Biol Chem. 2014 Apr 11;289(15):10270-10275. doi: 10.1074/jbc.C113.541417. Epub 2014 Mar 4.
5
Association of a peptoid ligand with the apical loop of pri-miR-21 inhibits cleavage by Drosha.一种肽类似物配体与前体 miR-21 的顶端环结合,抑制 Drosha 的切割。
RNA. 2014 Apr;20(4):528-39. doi: 10.1261/rna.042911.113. Epub 2014 Feb 4.
6
RNAi factors are present and active in human cell nuclei.RNAi 因子存在于并活跃于人类细胞核中。
Cell Rep. 2014 Jan 16;6(1):211-21. doi: 10.1016/j.celrep.2013.12.013. Epub 2014 Jan 2.
7
A comprehensive characterization of the nuclear microRNA repertoire of post-mitotic neurons.全面描绘有丝分裂后神经元中的核微小 RNA 文库。
Front Mol Neurosci. 2013 Nov 26;6:43. doi: 10.3389/fnmol.2013.00043. eCollection 2013.
8
Beyond secondary structure: primary-sequence determinants license pri-miRNA hairpins for processing.超越二级结构:一级序列决定子赋予 pri-miRNA 发夹用于加工的许可。
Cell. 2013 Feb 14;152(4):844-58. doi: 10.1016/j.cell.2013.01.031.
9
Increased serum and urinary microRNAs in children with idiopathic nephrotic syndrome.儿童特发性肾病综合征患者血清和尿液中 microRNAs 的增加。
Clin Chem. 2013 Apr;59(4):658-66. doi: 10.1373/clinchem.2012.195297. Epub 2013 Jan 23.
10
Human TNRC6A is an Argonaute-navigator protein for microRNA-mediated gene silencing in the nucleus.人类 TNRC6A 是一种 Argonaute 导航蛋白,可在核内介导 microRNA 介导的基因沉默。
RNA. 2013 Jan;19(1):17-35. doi: 10.1261/rna.034769.112. Epub 2012 Nov 13.